207 related articles for article (PubMed ID: 32748763)
1. Integrated System Pharmacology and
Hannan MA; Dash R; Haque MN; Choi SM; Moon IS
CNS Neurol Disord Drug Targets; 2020; 19(7):541-556. PubMed ID: 32748763
[TBL] [Abstract][Full Text] [Related]
2. Synthesis,
Gaurav I; Singh T; Thakur A; Kumar G; Rathee P; Kumari P; Sweta K
Curr Pharm Biotechnol; 2020; 21(15):1674-1687. PubMed ID: 32614743
[TBL] [Abstract][Full Text] [Related]
3. Withanolides from
Khanal P; Chikhale R; Dey YN; Pasha I; Chand S; Gurav N; Ayyanar M; Patil BM; Gurav S
J Biomol Struct Dyn; 2022 Aug; 40(12):5295-5308. PubMed ID: 33459174
[TBL] [Abstract][Full Text] [Related]
4. Extraction Optimization for Phenolic- and Withanolide-Rich Fractions from
Kumar S; Singh R; Gajbhiye N; Dhanani T
J AOAC Int; 2018 Nov; 101(6):1773-1780. PubMed ID: 29945694
[No Abstract] [Full Text] [Related]
5. Modulation of GPCR receptors common to gut inflammatory diseases and neuronal disorders, Alzheimer's and Parkinson's diseases as druggable targets through
Shukla R; Pahal S; Gupta A; Choudhary P; Misra K; Singh S
J Biomol Struct Dyn; 2023 Jul; 41(10):4485-4503. PubMed ID: 35491707
[TBL] [Abstract][Full Text] [Related]
6. RNAi of Sterol Methyl Transferase1 Reveals its Direct Role in Diverting Intermediates Towards Withanolide/Phytosterol Biosynthesis in Withania somnifera.
Pal S; Rastogi S; Nagegowda DA; Gupta MM; Shasany AK; Chanotiya CS
Plant Cell Physiol; 2019 Mar; 60(3):672-686. PubMed ID: 30541044
[TBL] [Abstract][Full Text] [Related]
7. Withania somnifera root extract inhibits MGO-induced skin fibroblast cells dysfunction via ECM-integrin interaction.
Liu X; Chen C; Lin Y; Liu Y; Cai S; Li D; Li L; Xiao P; Yi F
J Ethnopharmacol; 2024 Apr; 323():117699. PubMed ID: 38185262
[TBL] [Abstract][Full Text] [Related]
8. Dynamics of withanolide biosynthesis in relation to temporal expression pattern of metabolic genes in Withania somnifera (L.) Dunal: a comparative study in two morpho-chemovariants.
Dhar N; Rana S; Bhat WW; Razdan S; Pandith SA; Khan S; Dutt P; Dhar RS; Vaishnavi S; Vishwakarma R; Lattoo SK
Mol Biol Rep; 2013 Dec; 40(12):7007-16. PubMed ID: 24190485
[TBL] [Abstract][Full Text] [Related]
9. Direct evidence for GABAergic activity of Withania somnifera on mammalian ionotropic GABAA and GABAĻ receptors.
Candelario M; Cuellar E; Reyes-Ruiz JM; Darabedian N; Feimeng Z; Miledi R; Russo-Neustadt A; Limon A
J Ethnopharmacol; 2015 Aug; 171():264-72. PubMed ID: 26068424
[TBL] [Abstract][Full Text] [Related]
10. Exploring neuroprotective potential of Withania somnifera phytochemicals by inhibition of GluN2B-containing NMDA receptors: An in silico study.
Kumar G; Patnaik R
Med Hypotheses; 2016 Jul; 92():35-43. PubMed ID: 27241252
[TBL] [Abstract][Full Text] [Related]
11. Metabolomic and biotechnological approaches to determine therapeutic potential of Withania somnifera (L.) Dunal: A review.
Tripathi N; Shrivastava D; Ahmad Mir B; Kumar S; Govil S; Vahedi M; Bisen PS
Phytomedicine; 2018 Nov; 50():127-136. PubMed ID: 30466971
[TBL] [Abstract][Full Text] [Related]
12. Network ethnopharmacological evaluation of the immunomodulatory activity of Withania somnifera.
Chandran U; Patwardhan B
J Ethnopharmacol; 2017 Feb; 197():250-256. PubMed ID: 27487266
[TBL] [Abstract][Full Text] [Related]
13. Withanolides from Withania somnifera roots.
Misra L; Mishra P; Pandey A; Sangwan RS; Sangwan NS; Tuli R
Phytochemistry; 2008 Feb; 69(4):1000-4. PubMed ID: 18061221
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and bioequivalence of
Kim SK; Venkatesan J; Rathi P; Antony B
Heliyon; 2023 Dec; 9(12):e22843. PubMed ID: 38144272
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome analysis reveals in vitro cultured Withania somnifera leaf and root tissues as a promising source for targeted withanolide biosynthesis.
Senthil K; Jayakodi M; Thirugnanasambantham P; Lee SC; Duraisamy P; Purushotham PM; Rajasekaran K; Nancy Charles S; Mariam Roy I; Nagappan AK; Kim GS; Lee YS; Natesan S; Min TS; Yang TJ
BMC Genomics; 2015 Jan; 16(1):14. PubMed ID: 25608483
[TBL] [Abstract][Full Text] [Related]
16. Metabolite Profiling in Withania somnifera Roots Hydroalcoholic Extract Using LC/MS, GC/MS and NMR Spectroscopy.
Trivedi MK; Panda P; Sethi KK; Jana S
Chem Biodivers; 2017 Mar; 14(3):. PubMed ID: 27743505
[TBL] [Abstract][Full Text] [Related]
17. [Hair roots induction and culture of Withania somnifera and its withanolide A synthesis].
Wang FY; Sun YM; Lv CP; Cheng MQ; Zhang L; Sun M
Zhongguo Zhong Yao Za Zhi; 2014 Mar; 39(5):790-4. PubMed ID: 25204166
[TBL] [Abstract][Full Text] [Related]
18. Deciphering Molecular Mechanism of the Neuropharmacological Action of Fucosterol through Integrated System Pharmacology and
Hannan MA; Dash R; Sohag AAM; Moon IS
Mar Drugs; 2019 Nov; 17(11):. PubMed ID: 31766220
[TBL] [Abstract][Full Text] [Related]
19. Withanolide A is inherently de novo biosynthesized in roots of the medicinal plant Ashwagandha (Withania somnifera).
Sangwan RS; Das Chaurasiya N; Lal P; Misra L; Tuli R; Sangwan NS
Physiol Plant; 2008 Jun; 133(2):278-87. PubMed ID: 18312497
[TBL] [Abstract][Full Text] [Related]
20. Withania somnifera extracts induced attenuation of HIV-1: a mechanistic approach to restrict viral infection.
Jadaun P; Harshithkumar R; Gaikwad SY; Seniya C; Borse S; Gawai AA; Chavan-Gautam P; Tillu G; Mukherjee A
Virol J; 2023 Aug; 20(1):173. PubMed ID: 37537596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
